$0.00
37.50%
Nasdaq, Nov 25, 04:10 pm CET
ISIN
US62014P1084
Symbol
MOTS

Motus GI Holdings, Inc. Stock price

$0.00
-0.00 66.67% 1M
-0.14 99.64% 6M
-1.27 99.96% YTD
-4.00 99.99% 1Y
-152.76 100.00% 3Y
-480.00 100.00% 5Y
-1,314.00 100.00% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.00 37.50%
ISIN
US62014P1084
Symbol
MOTS
Sector

Key metrics

Market capitalization $0.00
Enterprise Value $-2.50m
P/E (TTM) P/E ratio 0.00
EV/FCF (TTM) EV/FCF 0.28
EV/Sales (TTM) EV/Sales -7.58
P/S ratio (TTM) P/S ratio 0.00
P/B ratio (TTM) P/B ratio 0.00
Revenue growth (TTM) Revenue growth -47.93%
Revenue (TTM) Revenue $330.00k
EBIT (operating result TTM) EBIT $-9.31m
Free Cash Flow (TTM) Free Cash Flow $-9.01m
Cash position $4.94m
EPS (TTM) EPS $-14.95
P/E forward 0.00
P/S forward 0.17
EV/Sales forward negative
Short interest 0.45%
Show more

Is Motus GI Holdings, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Motus GI Holdings, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Motus GI Holdings, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Motus GI Holdings, Inc.:

Buy
100%

Financial data from Motus GI Holdings, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '24
+/-
%
0.33 0.33
48% 48%
100%
- Direct Costs 0.92 0.92
41% 41%
279%
-0.59 -0.59
36% 36%
-179%
- Selling and Administrative Expenses 5.53 5.53
46% 46%
1,676%
- Research and Development Expense 2.60 2.60
55% 55%
788%
-8.72 -8.72
48% 48%
-2,642%
- Depreciation and Amortization 0.59 0.59
21% 21%
179%
EBIT (Operating Income) EBIT -9.31 -9.31
47% 47%
-2,820%
Net Profit -11 -11
42% 42%
-3,209%

In millions USD.

Don't miss a Thing! We will send you all news about Motus GI Holdings, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company was founded in September, 2016 and is headquartered in Fort Lauderdale, FL.

Head office United States
CEO Mark Pomeranz
Employees 15
Founded 2008
Website www.motusgi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today